Efficacy and Safety of Uprifosbuvir (MK-3682) + Ruzasvir (MK-8408) in Treating Hepatitis C Virus Infection Genotypes 1-6 (MK-3682-041)
Clinical trial NCT02956629 · TERMINATED
Trial details
- NCT number
- NCT02956629
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-16
- Primary completion
- 2017-12-22
- Enrollment
- 282
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.